These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 8354023)
1. Inhibition and induction of cytochrome P4502E1-catalyzed oxidation by isoniazid in humans. Zand R; Nelson SD; Slattery JT; Thummel KE; Kalhorn TF; Adams SP; Wright JM Clin Pharmacol Ther; 1993 Aug; 54(2):142-9. PubMed ID: 8354023 [TBL] [Abstract][Full Text] [Related]
2. Modulation of CYP2E1 activity by isoniazid in rapid and slow N-acetylators. O'Shea D; Kim RB; Wilkinson GR Br J Clin Pharmacol; 1997 Jan; 43(1):99-103. PubMed ID: 9056059 [TBL] [Abstract][Full Text] [Related]
3. Cytochrome P4502E in vivo and in vitro in the dwarf goat: effects of enzyme induction and the applicability of chlorzoxazone as marker substrate. Zweers-Zeilmaker WM; Maas RF; Horbach GJ; van Miert AS; Witkamp RF J Vet Pharmacol Ther; 1996 Jun; 19(3):245-50. PubMed ID: 8803884 [TBL] [Abstract][Full Text] [Related]
4. Influence of polymorphic N-acetyltransferase phenotype on the inhibition and induction of acetaminophen bioactivation with long-term isoniazid. Chien JY; Peter RM; Nolan CM; Wartell C; Slattery JT; Nelson SD; Carithers RL; Thummel KE Clin Pharmacol Ther; 1997 Jan; 61(1):24-34. PubMed ID: 9024171 [TBL] [Abstract][Full Text] [Related]
5. Effects of cytochrome P450 2E1 modulators on the pharmacokinetics of chlorzoxazone and 6-hydroxychlorzoxazone in rats. Chen L; Yang CS Life Sci; 1996; 58(18):1575-85. PubMed ID: 8649187 [TBL] [Abstract][Full Text] [Related]
6. Cytochrome P4502E1 inhibition by propylene glycol prevents acetaminophen (paracetamol) hepatotoxicity in mice without cytochrome P4501A2 inhibition. Thomsen MS; Loft S; Roberts DW; Poulsen HE Pharmacol Toxicol; 1995 Jun; 76(6):395-9. PubMed ID: 7479582 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of the metabolism of paracetamol by isoniazid. Epstein MM; Nelson SD; Slattery JT; Kalhorn TF; Wall RA; Wright JM Br J Clin Pharmacol; 1991 Feb; 31(2):139-42. PubMed ID: 2049229 [TBL] [Abstract][Full Text] [Related]
8. Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activity. O'Shea D; Davis SN; Kim RB; Wilkinson GR Clin Pharmacol Ther; 1994 Oct; 56(4):359-67. PubMed ID: 7955797 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of chlorzoxazone metabolism, a clinical probe for CYP2E1, by a single ingestion of watercress. Leclercq I; Desager JP; Horsmans Y Clin Pharmacol Ther; 1998 Aug; 64(2):144-9. PubMed ID: 9728894 [TBL] [Abstract][Full Text] [Related]
10. Assessment of cytochrome P4502E1 induction in alcoholic patients by chlorzoxazone pharmacokinetics. Girre C; Lucas D; Hispard E; Menez C; Dally S; Menez JF Biochem Pharmacol; 1994 Apr; 47(9):1503-8. PubMed ID: 7910460 [TBL] [Abstract][Full Text] [Related]
11. Ethanol increases content and activity of human cytochrome P4502E1 in a transduced HepG2 cell line. Carroccio A; Wu D; Cederbaum AI Biochem Biophys Res Commun; 1994 Aug; 203(1):727-33. PubMed ID: 8074729 [TBL] [Abstract][Full Text] [Related]
12. Decrease in cytochrome P4502E1 as assessed by the rate of chlorzoxazone hydroxylation in alcoholics during the withdrawal phase. Lucas D; Ménez C; Girre C; Bodénez P; Hispard E; Ménez JF Alcohol Clin Exp Res; 1995 Apr; 19(2):362-6. PubMed ID: 7625570 [TBL] [Abstract][Full Text] [Related]
13. Interaction between two probes used for phenotyping cytochromes P4501A2 (caffeine) and P4502E1 (chlorzoxazone) in humans. Berthou F; Goasduff T; Lucas D; Dréano Y; Le Bot MH; Ménez JF Pharmacogenetics; 1995 Apr; 5(2):72-9. PubMed ID: 7663531 [TBL] [Abstract][Full Text] [Related]
14. Metabolic oxidation and toxification of N-methylformamide catalyzed by the cytochrome P450 isoenzyme CYP2E1. Hyland R; Gescher A; Thummel K; Schiller C; Jheeta P; Mynett K; Smith AW; Mráz J Mol Pharmacol; 1992 Feb; 41(2):259-66. PubMed ID: 1538706 [TBL] [Abstract][Full Text] [Related]
15. Role of CYP3A in ethanol-mediated increases in acetaminophen hepatotoxicity. Kostrubsky VE; Szakacs JG; Jeffery EH; Wood SG; Bement WJ; Wrighton SA; Sinclair PR; Sinclair JF Toxicol Appl Pharmacol; 1997 Apr; 143(2):315-23. PubMed ID: 9144448 [TBL] [Abstract][Full Text] [Related]